RGD-modified PEGylated paclitaxel nanocrystals with enhanced stability and tumor-targeting capability
Zhigang Huang(University of Shanghai for Science and Technology), Weiyue Lu(University of Shanghai for Science and Technology), Jun Wang(University of Shanghai for Science and Technology), Zhepeng Liu(University of Shanghai for Science and Technology), Feng-mei Lv(University of Shanghai for Science and Technology), Shui-juan Cao(Fudan University), Yu Liu(Shanghai Center for Brain Science and Brain-Inspired Technology)
Cited by 71
Related Papers
Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect
|Journal of Controlled Release|2010|365
LyP-1-conjugated PEGylated liposomes: A carrier system for targeted therapy of lymphatic metastatic tumor
|Journal of Controlled Release|2011|139
Does government debt impede firm innovation? Evidence from the rise of LGFVs in China
|Journal of Banking & Finance|2022|102
Remote‐Loaded Platelet Vesicles for Disease‐Targeted Delivery of Therapeutics
|Advanced Functional Materials|2018|87
Platelet membrane-functionalized nanoparticles with improved targeting ability and lower hemorrhagic risk for thrombolysis therapy
|Journal of Controlled Release|2020|80